Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA PMTA and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding increased scrutiny on FDA/CTP for delayed enforcement Issues surrounding CBP resources for interdicting massive influx & mislabeling illicit vapes Issues surrounding retail inspections enforcement limitation Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes January 2025 Proposed Rule: Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products Issues surrounding efforts to prevent youth access to tobacco products Discussions regarding federal excise taxes and the taxation of tobacco products Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs); HR 1, THE ONE BIG BEAUTIFUL BILL
S. 464, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S. 2929/H.R. 5715, Tobacco Tax Equity Act Issues surrounding Internal Revenue Code 420 Discussions concerning the tax rate on corporate stock buybacks and U.S. multinationals foreign earnings Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes/duties on tobacco products Discussions concerning a retaliatory tax on international companies from countries that adopt extraterritorial tax schemes. Issues surrounding taxation of tobacco products
Discussions concerning the FY 2025 and FY 2026 appropriations bills; provisions related to the FDA regulation of tobacco.